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Snake venoms are complex mixture of enzymatic and non-enzymatic proteins. Non-
covalent protein–protein interaction leads to protein complexes, which bring about
enhanced pharmacological injuries by their synergistic action. Here we report identifica-
tion and characterization of a new Daboia russelii hemorrhagic complex I (DR–HC-I)
containing phospholipase A2 (PLA2) and non-enzymatic peptide. DR–HC-I was isolated
from the venom of D. russelii by CM-Shepadex-C25 and gel permeation chromatography.
Individual components were purified and identified by RP-HPL chromatography, mass
spectrometry and N-terminal amino acid sequencing. DR–HC-I complex was lethal to mice
with the LD50 dose of 0.7 mg/kg body weight with hemorrhagic and neurotoxic properties.
DR–HC-I complex consists of non-hemorrhagic PLA2 and neurotoxic non-enzymatic pep-
tide. The non-enzymatic peptide quenched the intrinsic fluorescence of PLA2 in a dose
dependent manner, signifying the synergistic interaction between two proteins. PLA2 and
peptide toxin in a 5:2 M ratio induced skin hemorrhage in mice with MHD 20 mg. However,
addition of ANS (1-Anilino-8-naphthalene sulfonate) to DR–HC–I complex inhibited skin
hemorrhagic effect and also synergic interaction. But there was no impact on PLA2 due to
this synergistic interaction, and indirect hemolytic or plasma re-calcification activity.
However, the synergistic interaction of PLA2 and non-enzymatic peptide contributes to the
enhanced venom-induced hemorrhage and toxicity of Daboia russellii venom.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Daboia russelii (Russell’s viper) is one of the most per-
ilous snakes that cause morbidity and mortality in Indian
subcontinent. Its venom consists of components that are
responsible for coagulopathy, necrosis, renal failure,
neurotoxicity, myotoxicity, cardiotoxicity, convulsions, hy-




. All rights reserved.Among these, hemorrhage on the site of bite and unhealed
wounds of the victimwere severe and major manifestation
of envenomation, though renal failure is considered as the
primary cause of death (Kularatne et al., 2011) (Warrell,
1989). Recent studies and clinical observations have indi-
cated higher case fatalities and more severe hemorrhagic
manifestations in D. russelii envenoming in Eastern India,
Myanmar and in other regions (Kumar and Gowda, 2006;
Mukherje et al., 2000; Senthilkumaran et al., 2012)
(Warrell, 1997).
Although hemorrhage is a well-known phenomenon in
the Daboia russelii bites, its mechanism of action needs to
be elucidated. Several researchers attributed hemorrhagic
activity to proteolysis toxins (Chakrabarty et al., 1993;
Ribeiro Filho et al., 2003). However, the presence of
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reported (Kasturi and Gowda, 1989; Kole et al., 2000; Toom
et al., 1969).
Hemorrhagic effect of D. russelii venom was mainly
attributed to proteases and PLA2s. PLA2 hemorrhagins such
as VRV-PL-VIIIa (Kasturi and Gowda, 1989) and VRV-PL-VI
(Vishwanath et al., 1988) were purified and characterized
from Southern and Northern regional D. russelii venoms
respectively. Hemorrhagic PLA2’s purified from D. russelii
venom have shown organ specificity in test animals. For
example, the most basic phospholipase A2 of Southern In-
dian venom is shown to induce lung hemorrhage (Kasturi
and Gowda, 1989).
D. russelii venom from Western India reported to cause
atrophic effects on the reproductive organs in animals
(Kumar et al., 2008). A protease from the same source has
been reported to cause hemorrhage in the eyes, lungs and
liver (Jayanthi and Gowda, 1990). A hemorrhagin, isolated
from Eastern Indian region has been reported to induce
severe lung and liver hemorrhage and dermal hemorrhage
(Chakrabarty et al., 1993; Chen et al., 2008). A non pro-
teolytic toxin has been reported to induce intense intestinal
hemorrhage and to a lesser extent skeletal muscle hemor-
rhage in mice (Kole et al., 2000).
Although, most of the snake venom research has been
focused on individual toxin and their action, and very
interesting synergistically acting toxin complexes have
been reported. Snake venom PLA2s participates in most of
the snake venom protein complexes. In many cases it in-
teracts with other proteins which are either PLA2s or
derived from PLA2 precursors or peptides. Some of the
dimeric PLA2–PLA2 complexes include Ceruleotoxin from
Bungarus fasciatus (Bon and Saliou, 1983), Vaspin from
Vipera aspis (Jan et al., 2002). Besides these, synergistically
acting PLA2s have been isolated and characterized from
viperidae venoms. For example, neurotoxic complexes such
as ‘Crotoxin’ (Slotta and Primosigh, 1951) ‘Vipoxin’
(Tchorbanov et al., 1978) and ‘Mojave toxin’ (Cate and
Bieber, 1978) are composed of acidic and basic subunits,
which interact synergistically to enhance the toxicity
in vivo.
In this study, we report the identification and purifica-
tion of a potent hemorrhagic and neurotoxic complex from
the Eastern regional D. russelii venom, consisting of PLA2
and non-enzymatic peptide (DNTx-II). It has been desig-
nated as D. russelii hemorrhagic complex-I (DR–HC-I).
Further, individual components of hemorrhagic complex
were characterized and their synergism was demonstrated
using spectrofluorometer and in vivo studies.
2. Materials and methods
2.1. Materials
CM-Sephadex C-25 and Sephadex G-50 were purchased
from Sigma (St. Louis, MO, USA). Para-bromophenacyl
bromide, ANS (1-anilino-8-naphthalene sulfonate) and
low range molecular weight protein markers were pur-
chased from Sigma chemicals, St. Louis, USA. [14C] Oleic
acid was obtained fromPerkin Elmer Life Sciences Inc., USA.
Fatty acid free BSA (bovine serum albumin) was obtainedfrom PAA Laboratories GmbH, Austria. Scintillation cocktail
was obtained from Packard Biosciences BV, The
Netherlands. All other chemicals and reagents of analytical
grade were purchased from SRL chemicals, Mysore, India.
2.2. Venom
Lyophilized D. russelii venom of Eastern region was
purchased from Hindustan Snake Park, Burdwan district of
Kolkata, Kolkata.
2.3. Animals
Swiss male,Wister miceweighingw20 g andmale frogs
(Rana hexadactyla) were procured from Central Animal
House, Department of Studies in Zoology, University of
Mysore, Manasagangotri, India. Animal care and handling
were conducted in accordance with the CPCSEA office
guidelines, University of Mysore division, Mysore, India.
2.4. CM-Sephadex C-25 ion-exchange chromatography
The venom (200 mg dry weight) dissolved in 4 ml of
0.02 M-phosphate buffer (pH 7.0), was loaded on to CM-
Sephadex C-25 column (1.5  104 cm) equilibrated with
0.02 M phosphate buffer (pH 7.0). Stepwise elution was
carried out with phosphate buffer of various molarities and
pH as indicated in Fig. 1A. Flow-rate was adjusted to 25 ml/
h and 2.5 ml fractions were collected. Protein elution was
monitored at 280 nm using UV–VIS 1601 Shimadzu
spectrophotometer.
2.5. Sephadex G-50 gel-permeation chromatography
The pooled fractions of 9th peak from CM-Sephadex C-
25 column were concentrated, and subjected to gel-
permeation chromatography on Sephadex G-50 column
(1.0  50 cm). The columnwas pre-equilibrated with 0.5 M
NaCl. The protein was eluted with 0.5 M NaCl, with flow
rate of 1.5 ml/6 min. The protein elution was monitored as
explained earlier using Shimadzu spectrophotometer.
2.6. Reversed phase high performance liquid chromatography
(RP-HPLC)
The fractions of peak A and B from Sephadex G-50 gel
permeation chromatographywere subjected to RP-HPLC on
a Vydac C18 (250  4.6 mm, 10 mm particle size, 300 A pore
size) column in a Shimadzu LC-10AVP system with dual
wavelength detector. The column was equilibrated with
0.1% trifluoroacetic acid (TFA) and eluted using a linear
gradient of 70% acetonitrile in 0.1% TFA at a flow rate of
1 ml/min. The elution was carried out using a 0–100%
gradient of solvent B (70% acetonitrile) against solvent A
(0.2% TFA).
2.7. Electrophoresis
The native gel electrophoresis was carried out at pH 4.3
using b-alanine-acetic acid buffer with methyl green as
tracking dye (Davis, 1964). Electrophoresis was carried out
Fig. 1. Daboia russelii hemorrhagic complex-I purification. (A) CM-Sephadex-C-25 column (1.5  104 cm) was pre-equilibrated with 0.02 M-phosphate of buffer
pH 7.0; fractionation was carried out as described in materials and methods. (B) The peak 9 (7 mg protein) from CM-Sephadex C-25 column was loaded into
Sephadex G-50 gel-permeation chromatography column (1.5  115 cm) pre-equilibrated with saline. 1.5 ml fractions were collected and protein elution
monitored as described in material and methods. (C) Electrophoresis under acidic condition at pH 4.3 using b-alanine-acetic acid buffer with methyl green as
tracking dye.
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stant current of 90 V. SDS-PAGE (sodium dodecyl sulfate
polyacrylamide gel electrophoresis) was carried out ac-
cording to themethod of Laemmli (Laemmli,1970) on 12.5%
polyacrylamide gel containing 0.1% SDS. The bands were
visualized by staining with Coomassie brilliant blue R-250.
2.8. Molecular weight determination by MALD-TOF MS
Molecular weight of the PLA2 and DNTx-II were deter-
mined by MALDI-TOF MS. The matrix used for both the
samples was sinapinic acid. Linear spectrawere obtained in
the positive ion mode on a Reflex IV MALDI-TOF mass
spectrometer (Bruker Daltonics, Bremen, Germany). The
M þ H and M þ 2H signals of horse heart myoglobin were
used for external calibration of the spectra.
2.9. N-terminal amino acid sequencing
Sequencing was carried out using an applied Bio system
Precise Edman Sequencer. The chemical process employedby the protein sequencer to determine the amino acid
sequence was derived from the degradation method
developed by Edman. N-terminal sequence homology was
analyzed using the NCBI-BLAST database search. Website:
http://www.ncbi.nlm.nih.gov/BLAST/.
2.10. PLA2 assay
PLA2 activity was assayed with [14C] oleate-labeled
autoclaved Escherichia coli cells as substrate according to the
method of Vishwanath et al. (1993). The reaction mixture
(350 ml) contained 100 mM Tris–HCl, pH 8.0; 5.0 mM Ca2þ
and 3.15  109 autoclaved E. coli cells (corresponding to
10,000 CPM and 60 nmole of lipid phosphorous). The reac-
tion components weremixed in the following order: Buffer,
Ca2þ, water and enzyme source (5–20 mg), and incubated at
37 C for 60 min. The reaction was initiated by adding
labeled E. coli cells. The reaction was terminated by adding,
100 ml of 2 M HCl and 100 ml of fatty acid free BSA (100 mg/
ml). Then the tubes were vortex mixed and centrifuged at
20,000 g for 5 min. An aliquot (140 ml) of the supernatant
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lation cocktail and counted in a Hewlett Packard Liquid
Scintillation Analyzer TRI – CARB 2100 TR.
2.11. Pharmacological properties
2.11.1. Determination of LD50
LD50 values for the DR–HC-I, purified PLA2 and DNTx-II
were calculated according to the mathematical scheme
adopted by Meier and Theakston (1986). The toxins were
injected (i.p) separately into groups of 12 mice with doses
ranging from 1 to 10 mg/kg body weight. Survival time of
each animal was recorded for 24 h.
2.11.2. Hemolytic activity
Indirect/direct hemolytic activities were assayed as
described by Boman and Kaletta (1957). The substrate for
direct lytic activity was prepared by suspending 1 ml of
packed fresh human RBC in 9 ml of saline. Whereas, the
substrate for indirect hemolytic activity was prepared by
suspending 1 ml of packed fresh human RBC and 1 ml of
fresh hens egg yolk in eight ml of PBS (phosphate buffer
saline). To one ml of the suspension 20–50 mg venom
samples DR–HC-I, PLA2 or DNTx-II were added and incu-
bated for 45 min at 37 C and the reaction was stopped by
adding 9 ml of ice-cold PBS. The positive control received
20 mg of venom alone. The suspension was centrifuged at
2000 rpm for 20 min, and then the released hemoglobin
was spectrophotometrically read at 530 nm.
2.11.3. Re-calcification time assay
Anticoagulant activity was determined according to the
modified method of Condrea et al. (1981). Platelet poor
plasma was prepared by diluting whole blood in the ratio
nine parts blood to 1 part 0.13 M Tri-sodium citrate. The
mixture was centrifuged twice at 2500 g for 15 min. The
platelet poor plasma was aliquot and stored at 70 C until
next use. To 300 ml of platelet poor plasma 5 mg–60 mg DR–
HC-I, PLA2 and DNTx-II in 0.01 M Tris–HCl buffer (pH 7.4)
were added. The mixture was incubated for 60 s at 37 C.
Clot formation was initiated by the addition of 30 ml of
0.25 M CaCl2 and the time interval required for the clot
formation was recorded.
2.11.4. Hemorrhagic activity
Hemorrhagic activity was determined as described by
Kondo et al. (1960). For positive control, groups of three
mice were injected (s.c) separately with the 10 mg of venom
alone. And DR–HC-I, PLA2 and DNTx-II were injected
separately. After three hours, mice were anesthetized by
anesthetic diethyl ether and sacrificed. Dorsal surface of the
skin was removed for observation of Hemorrhagic spot.
Various concentrations of DR–HC-I complex/PLA2/DNTx-II
(0–50 mg) were diluted in saline, and was injected intra-
dermal (fixed volume, 100 ml). Control sites were injected
with saline buffer alone. After three hours, the mice were
euthanized and the dorsal skin was removed and hemor-
rhagic spot on the inner surface of the skin was measured.
The minimum hemorrhagic dose (MHD) was defined as the
amount of venom or enzyme capable of producing a
hemorrhagic spot of 5 mm in diameter.2.11.5. Edema inducing activity
Induction of edema was determined as described by
Vishwanath et al. (1988). Groups of five mice were injected
in the right footpadwithdifferent concentrations ofDR–HC-
I, PLA2 and DNTx-II in 10 ml saline. Animals receiving only
10 ml of saline served as controls. After 45 min the animals
were euthanized by cervical dislocation and the legs were
removed at the ankle joints and weighed individually. The
edema ratio was calculated using the formula: Edema
ratio¼weight of edematous leg/weight of normal leg 100.
2.11.6. Neurotoxicity
The experimental conditions were set up as described by
Harvey et al. (1984). Sciatic nerve gastrocnemius muscle
preparationwas isolated from themale frogs (R. hexadactyla)
weighing18–20g.The isolatednervemusclepreparationwas
mounted in10mlorganbathcontainingKrebs solutionof the
following composition in milli-moles: NaCl, 4.7; MgSO4, 1.2;
KHPO4, 1.2; CaCl2, 2.5; NaHCO3 and glucose, 11.1. Indirect
twitches were evoked by electrical stimulation of the nerve
by supramaximal voltage (0.2ms, 0.1Hz). DR–HC-I, PLA2 and
DNTx-II (0.5–20 mg/ml) were left in contact with the nerve
preparation for 1 h or until the twitch response abolished.
2.11.7. Effect of PLA2–DNTx-II interaction on pharmacological
properties of PLA2
The mixture containing the PLA2 and DNTx-II in the
molar ratio of 5:2was tested for the PLA2 activity, hemolytic,
edema inducing, and hemorrhagic effects, as explained in
their respective methods.
2.12. Fluorimetric monitoring of PLA2 and peptide interaction
An intrinsic fluorescence emission spectrum of PLA2 and
DNTx-II was recorded using Shimadzu RF 5000 spectro-
flurophotometer. The PLA2 was incubated with 20 mM
phosphate buffer, pH 7.5 at different concentrations of
DNTx-II in a total volume of 3 ml. The mixture was incu-
bated at 37 C for 15 min before recording the fluorescence
emission spectra. The excitation was fixed at 280 nm in all
the fluorescence emission studies.
2.13. Effect of (ANS) 1 anilino-8-naphthalene sulfonate on
PLA2
1-Anilino-8-naphthalene sulfonate is an anion, conven-
tionally considered to bind to pre-existing hydrophobic
(nonpolar) surfaces of proteins. ANS binding to PLA2 was
followed by spectrofluorescence emission. A 2 ml solution
contained4nmolesofPLA2 in20mMphosphatebuffer, pH7.5
was incubated with different molar ratios of ANS. Fluores-
cence emission spectra of PLA2 alone andmixture of PLA2 and
ANSwas recorded in the rangeof 400–600nmafterexcitation
at 375 nm. Further, DNTx-II was added to the ANS saturated
PLA2 and emission spectra was recorded as described above.
2.14. Statistical analysis
All numerical results were analyzed using the GraphPad
Prism software (San Diego, CA, USA) and are expressed as
the mean  standard error (S.E.).
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3.1. Purification and characterization of DR–HC-1
D. russelii venom, upon fractionation on cation exchange
chromatography column gave 18 peak profiles (Fig. 1A).
Peak 9 eluted in 0.09 M phosphate buffer pH 7.3, accounted
for 3.5% of the total venom protein loaded. It released radio
labeled fatty acid from E. coli cells containing phospholipids
specifically labeled at Sn-2 position with [C14] oleate,
indicating the presence of PLA2.
Lyophilized peak 9 fractions (7 mg of protein) on gel-
permeation chromatography (Sephadex G-50), resolved
into two major peaks A, B and a minor shoulder, in the
presence of 0.5 mM Nacl (Fig. 1B). The peak A possesses
PLA2, indirect hemolytic, anticoagulant and edema
inducing activities (Table 1), while peak Bwas devoid of any
enzymatic activity. Whereas, a minor shoulder was nega-
tive for protein contents, in protein estimation assay and
also it was devoid of any toxic effect. Polyacrylamide gel
electrophoresis (PAGE) was carried out in acidic conditions
that facilitate the movement of basic proteins. PLA2 and
non-enzymatic peptide (DNTx-II) gave single band each.
But the mobility of PLA2 and the DNTx-II differ from each
other (Fig. 1C). PLA2 and DNTx-II on RP-HPLC gave a single
sharp symmetric peak with retention time of 49.012 and
40.00 min respectively (Figs. 2A and 3A), which confirms
the homogeneity of the proteins. The molecular weight of
PLA2 and DNTx-II was found to be 13,432.756 and 6745.9,
respectively (Figs. 2B and 3B), determined by MS-MALDI.
N-Terminal sequence analysis of the PLA2 and DNTx-II
gave NLFQFAEMIVKMTGK and IKCFITPDUTSQACP se-
quences, respectively.3.2. Pharmacological characterization of complex and
individual components
Peak 9 (Fig. 1A) induced skin hemorrhage in mice with
an MHD of 30 mg and edematous hemorrhage in foot pad,
hence designated as DR–HC-I. It was lethal to mice withTable 1
Biochemical and pharmacological properties of PLA2 and non-enzymatic
peptide.
PLA2 Peptide DR–HC–I
PLA2 Specific activity nmolesa 25 NA 15
LD50/Kg 7.4  0.2 0.24  0.4 0.7
Indirect hemolytic activityb (10 mg) 80% NA 85%
Direct hemolytic activityb (10 mg) NA NA NA
Plasma re-calcification time (2 mg)c 2.40 min NA 2.30 min
Edematic ratiod 155  5 141  6 168  5
Hemorrhage (skin) NA NA 30 mg
NA; No activity.
a Phospholipase A2 activity: Specific activity is expressed as fatty acid
released in nmoles/min/mg of protein. Values are presented as an average
of three experiments.
b Complete hemolysis of the erythrocytes by the addition of 10 ml
distilled water is taken as 100%. Values are expressed asmean (SD) (n¼ 6).
c The clotting time of normal plasma in the absence of PLA2 was 1 min
and 50 s.
d Edema ratio-weight of the edematous leg 100/weight of the normal
leg. The values are expressed as mean  S.D. (n ¼ 4).LD50 dose of 0.7 mg/kg body weight. Animals injected with
the toxin showed neurotoxic symptoms such as respiratory
distress, hind limb paralysis, lacrimation, convulsions and
profuse urination. DR–HC-I also possessed direct hemolytic
and plasma re-calcifications activities (Table 1).
The PLA2 (peak A, from Fig. 1B) alone was toxic to mice
with LD50 (i.p.) dose of 7.4 mg/kg body weight. The animals
did not show any signs/symptoms of neurotoxicity. The
Daboia neurotoxin-II (DNTx-II) (peak B, from Fig. 1B)
showed neurotoxic symptoms with LD50 of 0.24 mg/kg
body weight (Table 1). The post-mortem examination
revealed neither bleeding in the peritoneal cavity nor any
visible damage to vital organs such as liver, lungs and
kidney. Further, histological studies confirmed that there
were no effects on vital organs (data not shown).
The PLA2 alone induced non-hemorrhagic edema in the
footpads of mice. Edematic ratio 145 5 reachedmaximum
in 45 min after injection. Additionally, PLA2 alone showed
indirect hemolytic and Plasma re-calcification activity
(Table 1). Whereas, DNTx-II did not have any of these
activities.
The isolated nerve-muscle preparation in Krebs solution
evoked muscle contraction that was well maintained dur-
ing a control period of 60–80 min. DR–HC-I and its indi-
vidual components decreased the frog gastrocnemius
muscle twitch height in a time dependent manner on in-
direct stimulation (Fig. 5). DR–HC-I and DNTx-II, at 10 mg/
ml, inhibited the indirectly stimulated twitch response in a
time dependent manner (Fig. 5).
3.3. Protein–protein interaction
PLA2 and DNTx-II exhibited the intrinsic fluorescence
emission (Fig. 6A). Both of them showed maximum emis-
sion intensity between 350 and 360 nm at a concentration
of 0.5 mg/3 ml (Fig. 6A). This confirms the presence of
tryptophan in PLA2 and DNTx-II. The DNTx-II quenched the
intrinsic fluorescence of PLA2 in a dose dependent manner.
At a molar ratio of 5:2 (PLA2: DNTx II) 50% decrease in the
relative intrinsic fluorescence of PLA2 was observed
(Fig. 6B). When PLA2 was treated with different molar
concentrations of ANS, the fluorescence emission intensity
of ANS increased and it reached the saturation point at
PLA2: ANS concentration of 1:80 mmol (Fig. 7).
The individual components of DR–HC-I did not exhibit
hemorrhage at the site of injection (Fig. 4C and D). However
the mixture of PLA2 and DNTx-II in the molar ratio of 5:2
induced hemorrhage at the site of injection with MHD of
20 mg. In the presence of ANS they did not induce hemor-
rhage at the site of injection (Fig. 4E).
4. Discussion
Snake venoms are complex mixtures of enzymatic and
non-enzymatic proteins/peptides. Most of the snake
venom research has been focused on purification and
characterization of abundant or highly toxic components
from the venom. However, relatively less interest has been
paid to understand the synergistic effect on pharmacolog-
ical properties of the venoms. The synergism have impor-
tant role in elevating the debilitating effect of the venom.
Fig. 2. RP-HPLC and molecular weight analysis of PLA2. (A) PLA2 (peak-A) was applied on a Vydac C18 (250  4.6 mm, 10 mm particle size, 300 A pore size) column
in a Shimadzu LC-10AVP system with dual wavelength detector. The column was equilibrated with 0.1% Trifluoroacetic acid (TFA). They were eluted using a 0–
100% gradient of solvent B (70% acetonitrile) against solvent A (0.1% TFA). (B) Peak-A linear spectra were obtained in the positive ion mode on a Reflex IV MALDI-
TOF mass spectrometer (Bruker Daltonics, Bremen, Germany). The matrix used for the sample was sinapinic acid. (C) SDS-PAGE of Eastern regional Daboia russelii
venom and PLA2 under reducing and non-reducing condition. M-marker, 1, 2 Daboia russelii venom, 3, 4 PLA2 under reducing and non-reducing condition
respectively.
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regional Daboia russellii venoms, Eastern regional venom
was found to be the most toxic with the LD50 of 1.1 mg/kg
body weight (Kumar and Gowda, 2006). On the other hand,
the toxic principles such as PLA2s, responsible for the
toxicity of Southern regional venom are absent in Eastern
regional venom, but exhibited high toxicity. This may be
due to the consequence of synergistically acting complex
and non-enzymatic toxic peptides (Kumar and Gowda,
2006; Venkatesh et al., 2013).
A hemorrhagic complex-I was isolated from Eastern
regional D. russellii venom by single step purification usingCM-Sephadex C-25 ion-exchange column chromatography.
The complex (DR–HC-I) showed very potent skin hemor-
rhagic activity with a MHD of 30 mg (Fig. 4) and a LD50 value
of 0.7 mg/kg body weight. DR–HC-I possesses PLA2 activity.
It was resolved into 2 peaks on G-50, peak A had PLA2 ac-
tivity and peak B was devoid of any enzymatic activity. The
molecular weight of the PLA2 and DNTx-II was found to be
13,432.756 and 6745.9 respectively (Table 1). Therefore,
peak-A represents a typical PLA2. From the molecular
properties peak-B appears to be a peptide toxin.
By comparing N-terminal sequence of PLA2 with those
available in data banks, it was found that the sequences was
Fig. 3. RP-HPLC and molecular weight analysis of DNTx-II toxin. (A) Peak-B was applied on a Vydac C18 (250  4.6 mm, 10 mm particle size, 300 A pore size)
column in a Shimadzu LC-10AVP systemwith dual wavelength detector. The columnwas equilibrated with 0.1% Trifluoroacetic acid (TFA). They were eluted using
a 0–100% gradient of solvent B (70% acetonitrile) against solvent A (0.1% TFA). (B) Peak-B linear spectra were obtained in the positive ion mode on a Reflex IV
MALDI-TOF mass spectrometer (Bruker Daltonics, Bremen, Germany). The matrix used for the sample was sinapinic acid. (C) SDS-PAGE of DNTx-II under reducing
condition.
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2007; Tsai et al., 1996) (Table 2). On the other hand, the
N-terminal amino acid sequence of the DNTx-II peptide
showed 100% homology with cytotoxin/cardiotoxin from
Naja naja atra, upon blast search (Table 3). The peptide post
synaptic neurotoxins belong to a family of short and long
chain alpha-neurotoxins. Short alpha-neurotoxins consists
of 60–62 amino acid residues and include 4 disulfide
bridges, whereas long alpha-neurotoxins have 66–75 resi-
dues and 5 disulfides. Four disulfide bonds are conserved in
all family members (Endo and Tamiya, 1991).
The peak-A and peak-B in native PAGE moved to
different distances and their relative mobility variedsuggesting that they are distinctly different proteins. The
DNTx-II found to be more basic compared to PLA2. The
homogeneity of the PLA2 was confirmed by its appearance
as a single peak in RP-HPLC. The hemorrhagic complex
PLA2 appears to be quite distinct from the other PLA2s
isolated from Southern and Northern regional Russell’s
viper venom. Among the PLA2s isolated from the Indian
Russell’s viper venom, VRV-PL-V is most toxic with the LD50
1.8 mg/kg body weight. It possesses neurotoxicity, myo-
toxicity, and high anticoagulant activity. This is followed by
VRV-PL-VIIIa with mild neurotoxicity, myotoxicity and lung
hemorrhagic activity. In contrast, the hemorrhagic complex
PLA2 is least toxic and it did not induce any signs and
Fig. 4. Hemorrhagic effect of DR–HC-I and DNTx-II. Hemorrhagic effect of (A) DR–HC-I (10 mg) (B) PLA2: DNTx-II (5:2) (10 mg) (C) PLA2 alone (30 mg) and (D)
DNTx-II alone (20 mg), (E) PLA2: DNTx-II (5:2) (30 mg), in the presence of ANS (100 mM). Experiments were carried out as explained in methods.
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also it tested negative for neurotoxicity on frog sciatic
gastrocnemius muscle preparations. The Eastern PLA2
alone did not induce myotoxicity and also MED is low
compared to VRV-PL-V and VRV-PL-VIIIa (Table 1).4.1. Synergistic interaction of PLA2 and DNTx-II
Both DNTx-II and PLA2 consists of tryptophan, which is
confirmed by fluorescence emission spectrum. Since they
are found to act synergistically, we determined the DNTx-II
ability to interact with PLA2 by fluorescence spectroscopy.
The change in intrinsic fluorescence reflectsFig. 5. Effect of DR–HC-1 and DNTx-II on twitch responses of Rana hex-
adactyla sciatic nerve gastrocnemius muscle. Twitch-response curve for
control (PBS) and toxin DNTx-II (10 mg/ml), Native DR–HC-1 (10 mg/ml), DR–
HC-1 (PLA2: DNTx-II, in 5:2 M ratio) (10 mg/ml), Twitch evoked by indirect
stimulation (0.1 Hz  0.5 ms)  SEM (n ¼ 4), response at 0 min and 60 min
Points represent the mean  SEM for six determinations.conformational change in protein due to substrate or ligand
interaction (Fawzy et al., 1988). Fluorescence emission in-
tensity of PLA2 was quenched upon the addition of non-
enzymatic peptide in a concentration dependent manner.
At a molar ratio of 5:2 PLA2: DNTx-II, the quenching was
maximum (Fig. 6B), suggesting that DNTx-II interacts with
the PLA2 to form a complex.
In the snake venom complexes, the role of the non-
enzymatic component is believed to be that of a protec-
tive ‘chaperone’ (Choumet et al., 1993; Kini, 2003). The
non-enzymatic component in the complexes are known to
perform facilitator function. They enable the Phospholi-
pases to selectively attach to the appropriate membrane. At
5:2 M ratio it was noticed that the complex acts as a
different toxic molecule and induces hemorrhage at the site
of injection. On the other hand, either the PLA2 or DNTx-II
individually did not induce hemorrhagic effect (Fig. 4). This
suggests that the DNTx-II contributes significantly towards
the enhancement of hemorrhagic activity. Hence, the
hemorrhagic complex appears to undergo synergistic
interaction in the molar ratio of 5:2. The reconstituted
complex in 5:2 M ratio is more toxic then the native one
(PLA2 and DNTx-II present in 2.6:1.2 M ratio). In the pres-
ence of ANS, the enhancement of the hemorrhagic activity
and lethal potency are abolished (Fig. 4E). ANS is an anion,
which binds specifically to hydrophobic site on the surface
of the PLA2 molecule and prevents the non-covalent
interaction between the PLA2 and DNTx-II.
In the case of neurotoxin complexes such as Crotoxin,
Vipoxin andMojave toxin isolated from C. durissus terrificus
(Hendon and Fraenkel-Conrat, 1971; Slotta and Primosigh,
1951), Vipera ammodytes ammodytes (Tchorbanov et al.,
1978) and Crotalus scutulatus scutulatus (Cate and Bieber,
Fig. 6. Fluorometric analysis of synergistic interaction of PLA2 and DNTx-II.
(A) A florescence emission spectrum of PLA2 and DNTx-II (0.2 mg/ml in
Phosphate buffer saline, pH 7.4) was recorded in the range of 300–400 nm
after exciting at 280 nm in Shimadzu RF 5000 spectrofluorophotometer. (B)
Effect of DNTx-II on fluorescence emission spectra of PLA2, to a fixed con-
centration of PLA2 various nmoles of DNTx-II was added as shown in the
diagram. Fluorescence emission spectra were recorded after exciting at
280 nm as described in methods.
Fig. 7. Effect of PLA2 on the fluorescence emission spectra of ANS. 1-Anilino-
8-naphthalene sulfonate is an anion, conventionally considered to bind to
pre-existing hydrophobic surfaces of proteins. ANS binding to PLA2 was
followed by spectrofluorescence emission spectra. 2 ml solution contained
4 nmoles of PLA2 in 20 mM phosphate buffer, pH 7.5 was incubated with
different molar ratios of ANS. Spectra were recorded as explained in
methods.
Table 2
N-terminal sequence alignment of Daboia russelii PLA2 from hemorrhagic
complex DR–HC-I with NCBI Blast searched sequences.
Name Sequence Accession no References
D. russelii-PLA2 NLFQFAEMIVKMTGK
D. russelii NLFQFAEMIVKMTGK DQ365976.1
D. russelii NLFQFAEMIVKMTGK AAB47212.1 [27]
D. russelii siamensis NFFQFAEMIVKMTGK 2H4C_A [28]
Table 3
N-terminal sequence alignment of DNTx-II, with NCBI Blast searched se-
quences. CM, 5 a Long chain neurotoxin, LN1, Naja haje haje; Long chain
neurotoxin-a of Naja nivea (cape cobra).




M. Venkatesh, V. Gowda / Toxicon 73 (2013) 111–120 1191978) venoms, respectively are composed of basic phos-
pholipase associated with an acidic non-enzymatic
component. And also peptides inhibited the enzymatic ac-
tivity of phospholipase in vitro. On the other hand, in hem-
orrhagic complex, both non-enzymatic peptide and PLA2
are basic in nature, which is confirmed by their movement
in acidic PAGE and also their elution behavior in ion ex-
change chromatography. They differ from each other in
their relative mobility under acidic condition. Interestingly,
unlike above-mentioned complexes, the DNTx-II doesn’t
inhibit the enzymatic activity of D. russelii venom PLA2.
In conclusion, hemorrhage is one of the main patho-
logical manifestation upon D. russelii bites, but hemor-
rhagic components alone are less toxic. Based on the
findings, we conclude that, “the toxicity and pharmaco-
logical effects of D. russelii venom is due to the synergistic
effect of toxic peptides”.
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